Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001910857 | SCV002166298 | uncertain significance | Glycogen storage disease IXa1 | 2023-07-05 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PHKA2 protein function. ClinVar contains an entry for this variant (Variation ID: 1390884). This variant has not been reported in the literature in individuals affected with PHKA2-related conditions. This variant is present in population databases (rs145406549, gnomAD 0.04%), and has an allele count higher than expected for a pathogenic variant. This sequence change replaces isoleucine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 262 of the PHKA2 protein (p.Ile262Ser). |
Mayo Clinic Laboratories, |
RCV003481166 | SCV004225650 | uncertain significance | not provided | 2022-06-30 | criteria provided, single submitter | clinical testing | BS1, PP3 |